Bacteriophage Therapy for the Prevention and Treatment of Fracture-Related Infection Caused by Staphylococcus aureus: a Preclinical Study
Year: 2021
Type: article
Abstract: Because of the growing spread of antimicrobial resistance, the use of alternative prevention and treatment strategies is gaining interest. Although the therapeutic potential of bacteriophages has been demonstrated in a number of case reports and series over the past decade, many unanswered questions remain regarding the optimal application protocol. Furthermore, a major concern during phage therapy is the induction of phage neutralizing antibodies. This study aimed at providing a proof-of-concept of phage therapy in a clinically relevant rabbit model of fracture-related infection caused by Staphylococcus aureus. Phage therapy was applied as prophylaxis in a first phase, and as treatment of an established infection in a second phase. The development of phage neutralizing antibodies was evaluated in the treatment study. This study demonstrates that phage therapy can be useful in targeting orthopedic device-related infection, especially as prophylaxis; however, further research and improvements of these application methods are required.
Source: Microbiology Spectrum
Authors: Jolien Onsea, Virginia Post, Tim Buchholz, Hella Schwegler, Stephan Zeiter, Jeroen Wagemans, Jean-Paul Pirnay, Maya Merabishvili, Matteo D’Este, Stijn G. Rotman, Andrej Trampuz, Michael H. J. Verhofstad, William T. Obremskey, Rob Lavigne, R. Geoff Richards, T. Fintan Moriarty, Willem-Jan Metsemakers
Language: English
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,500
OpenAlex ID: W4200399212
